Anti-Human CD112R/PVRIG Antibody (CPA.7.021), FITC

Catalog No.

FHK16211

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

FITC

Target

C7orf15, CD112R, CD112 receptor receptor-related immunoglobulin domain-containing protein, PVRIG, Transmembrane protein PVRIG

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q6DKI7

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

CPA.7.021

Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT., PMID:37675979

Emergence of the CD226 Axis in Cancer Immunotherapy., PMID:35812451

Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer., PMID:34503073

Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors., PMID:34174928

Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy., PMID:33298247

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions., PMID:28623459

Document Download

Anti-Human CD112R/PVRIG Antibody (CPA.7.021), FITC.pdf